Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Brooks

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Alzheimer'S Disease : JAD|May 7, 2013
Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic miceOwen M Peters, Tatyana Shelkovnikova, Tatiana Tarasova, et al.
EMBO Molecular Medicine|October 4, 2023
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2Marzia Indrigo, Ilaria Morella, Daniel Orellana, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Alzheimer'S Disease : JAD|May 7, 2013
Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic miceOwen M Peters, Tatyana Shelkovnikova, Tatiana Tarasova, et al.
EMBO Molecular Medicine|October 4, 2023
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2Marzia Indrigo, Ilaria Morella, Daniel Orellana, et al.
Pageof 2